Leveraging deep generative modelling at the agent level in discrete-event simulations
summary
The gist
Leveraging deep generative modelling at the agent level in discrete-event simulations proposes a new approach to reduce simulation computational requirements by replacing computationally expensive…
In short
The research replaces computationally expensive sequences of stochastic events for a single agent with a deep generative model using Conditional Tabular Generative Adversarial Networks (CTGAN). This method improves simulation run-time by 86.6% while accurately recovering key health outcomes, demonstrating a crucial step toward enabling full-model emulators for complex agent-based simulations.
Key concepts
- Agent-level Deep Generative Modelling
- This involves using deep learning models, specifically GANs, directly on individual agents within a simulation. Instead of running every random event sequence for an agent during the simulation, the model learns to generate these sequences based on agent characteristics and conditions. This replaces slow stochastic sampling with a fast generative process.
- Conditional Tabular GAN (CTGAN)
- CTGAN is a specific type of Generative Adversarial Network used here to learn how to generate complex data outcomes from random noise, conditioned on specific input variables. It handles the varied data types found in health outcomes by learning a mapping from noise to the desired outcome, allowing for high-quality synthetic data generation.
- Detachable Sequences of Events
- This concept refers to sequences of events within an agent's simulation where intermediate state transitions only affect that specific agent's future stochastic events, not other agents or the overall environment. Identifying these detachable sequences allows researchers to remove them from the real-time simulation, reducing computational load without losing necessary population-level dynamics.
- Mean Disability Adjusted Life Years (DALYs)
- DALYs are a measure used in health economics to quantify overall disease burden, combining years of life lost due to premature death and years lived with disability. The paper shows the generative model can accurately recover the evolution of cause-specific DALYs, even when modeling complex multi-disease scenarios.
Terminology used across episodes
This episode discusses
- Leveraging deep generative modelling at the agent level in discrete-event simulations · Paper Radio
- Advances in Surrogate Modeling for Biological Agent-Based Simulations: Trends, Challenges, and Future Prospects
- Generative Adversarial Networks
- Modeling Tabular data using Conditional GAN
The paper
Leveraging deep generative modelling at the agent level in discrete-event simulations · Read on arXiv
Margherita Molaro, Matthew M. Grahamb, Oliver Watsona, Rachel E. Murray-Watsona, Martin Chalkleyc, Joseph H. Collinsd, Bingling Shea, ×Asif U., †Timothy B. Hallett
MRC Centre for Global Infectious Disease Analysis · Centre for Advanced Research Computing University College London · Centre for Health Economics University of York Institute for Global Health University College London
Emulators are often invoked to facilitate parameter inference in computationally intensive agent-based simulations (ABSs). Most approaches, however, require a large sample of pre-existing outputs on which such emulators can be trained. For computationally intensive simulations, this sample can be prohibitively expensive to generate. We propose a new approach to leverage emulators at the agent level in event-based ABSs to reduce the computational requirements of the simulation itself. We demonstrate this in a computationally intensive ``multi-disease'' ABS, Thanzi La Onse, which self-consistently simulates a wide range of medical conditions in a population. By applying conditional tabular generative adversarial networks to replace the modelling of one of the simulated causes of ill health, road traffic injuries (RTIs), we are able to improve its simulation run-time by 86.6% (95% bootstrap confidence interval [85.2, 88.1]), while recovering the evolution of cause-specific mean disability adjusted life years with a 13% error, despite the low assumed incidence of fatal RTIs (2%). Crucially, we do so while retaining the full ABS framework, and correctly recovering multi-disease dynamics. This represents a crucial step towards enabling full-model emulators for very computationally intensive simulations, and making large ABS amenable to rigorous parameter inference and a full understanding of parameter sensitivity.
Transcript
Introduction to the show: ident: Genomics Radio. Generated commentary on the latest computational biology and genomics papers.
Ines: I'm Ines.
Marcus: And I'm Marcus, here with Yuki.
Ines: We're looking at the paper: "Leveraging deep generative modelling at the agent level in discrete-event simulations".
Marcus: Here's the gist of the paper. Leveraging deep generative modelling at the agent level in discrete-event simulations proposes a new approach to reduce simulation computational requirements by replacing computationally expensive sequences of stochastic events with a deep generative modelling approach at the agent level in event-based ABSs By applying conditional tabular generative adversarial networks to replace the modelling of one of the simulated causes of ill health, road traffic injuries (RTIs), we are able to improve its simulation run-time by 86.6% (95% bootstrap confidence interval
85.2, 88.1: ) while recovering the evolution of cause-specific mean disability adjusted life years with a 13% error The Core Problem Addressed Agent-based simulations (ABSs) often face two technical challenges: a high dimensional parameter space and significant computational requirements While machine learning has been invoked to overcome these challenges through training of surrogate models or direct inference machines, they do not directly contribute to reducing the computational requirements of the ABS itself The paper proposes replacing computationally expensive sequences of stochastic events pertinent to a single agent with a deep generative modelling approach if intermediate state transitions only influence the subsequent sequence of stochastic events for the agent, but not other agents in the system or the environment itself This allows for reducing simulation run-time while fully retaining a stochastic approach to the sampling of outcomes How the Training Signal is Built The authors use a class of generative AI methods known as generative adversarial networks (GANs)
20: which are trained to directly learn a mapping from a random noise input z to outcome o, Gθ(z) → (o), thereby implicitly learning the probability distribution of interest Specifically, they employ a conditional tabular GAN (CTGAN) approach
21: accessed via the Synthetic Data Vault (SDV) library
22: to handle the heterogeneity in data types of outcomes They use 53 “scenarios” of service availability ck, divided into “designed” and random scenarios, to generate 530,000 outcome samples Training performance is validated using a 10-fold cross validation approach, testing both in-sample and out-of sample conditionality scenarios Where the Gains Come From The primary performance boost is quantified by the performance boost br for a given realisation r as br = 1 − tr,θ − t¯0 / (tr − t¯0) This represents the fraction of the RTI module CPU cost that is removed by adopting a generative AI approach in a particular realisation of the simulation The mean CPU run-time boost, obtained by bootstrapping across the 50 realisations considered, is 86.6% (95% bootstrap confidence interval
85.2, 88.1: ) This confirms that adopting an emulated approach provides a very large performance benefit Generalisability and Limitations The approach is applicable only in the case of “detachable” sequences of events, defined as sequences where intermediate state transitions only influence the subsequent sequence of stochastic events for the agent, but not other agents in the system or the environment itself The generalisability to other causes of ill health is limited because capturing some key intermediate events may still be essential for certain infectious diseases like HIV and ART Furthermore, the approach is restricted by the assumption that the interaction of individuals with their environment has no impact on the ability of the healthcare system to deliver services to other individuals The computational overhead introduced by rejection sampling on CTGAN additionally impacts performance In this work we have introduced a new approach for leveraging emulators at the agent level in discrete event ABSs, demonstrating the significant performance improvements that this can bring This represents a crucial intermediate step to enable rigorous analysis of computationally intensive models The approach is particularly well-suited to multi-disease ABSs, as explored in this work, and may facilitate the integration of diverse modelling frameworks to consistently capture population-wide health burdens across a broad spectrum of diseases and medical conditions in the future Page 1 --- Leveraging deep generative modelling at the agent level in discrete-event simulations Margherita Molaro, Matthew M.
Ines: Grahamb, Oliver Watsona, Rachel E.
Marcus: Murray-Watsona, Martin Chalkleyc, Joseph H.
Ines: Collinsd, Bingling Shea, Asif U.
Paper summary: Ines: So, looking at the whole paper "Leveraging deep generative modelling at the agent level in discrete-event simulations" and what we’ve covered today, the main point is that they’ve introduced a novel way to use emulators right where they matter most.
Marcus: They're moving away from training emulators on massive pre-existing output samples and instead using deep generative modelling directly at the agent level to reduce the simulation run time of discrete-event simulations in event-based systems.
Yuki: It’s about replacing expensive sequences of stochastic events for a single agent with an AI approach, specifically a conditional tabular GAN, which lets them capture complex outcome distributions without needing a huge training set for every scenario.
Ines: The real win they show is reducing the simulation run time by eighty six point six percent in their multi-disease simulation, while still recovering disability adjusted life years with only a thirteen point zero percent error.
Marcus: The implications are that this approach could be a crucial intermediate step for enabling full-model emulators, which are what we ultimately need for rigorous parameter inference and understanding the sensitivity of these large simulations to changes in policy or biology.
Yuki: It’s important to remember their stated limitations: this works best when event sequences are detachable, meaning they only affect the agent themselves, not the wider system dynamics. And it doesn't generalize perfectly across all diseases if you need those intermediate events for things like HIV or ART.
Conclusion: Ines: It is because they aren't just using an emulator somewhere far away; they are putting the generative modelling right at the agent level, in the discrete event simulation itself. That’s where it gets tricky.
Yuki: I think what’s interesting is how they frame it—it’s about making large simulations, like these multi-disease ones, actually runnable for people who want to test a lot of different scenarios.
Marcus: Exactly. The authors are talking about replacing the whole engine that drives the simulation with something much faster, while still keeping the underlying rules and dynamics intact.
Ines: And they claim this helps them recover disability adjusted life years with only a thirteen percent error, even when dealing with road traffic injuries, which is a specific cause of ill health.
Yuki: That’s a big number if you think about how much data you need to collect to get that kind of accuracy in real life for something like those injury sequences.
Marcus: The catch is they are being very specific about what this works on—only when the events are detachable, meaning an agent's state only affects its own future events, not other people or the environment around them.
Ines: That’s a huge limitation they point out—if you need those intermediate steps to model things like HIV or ART, this method just doesn't work as well.
Yuki: So it’s a powerful tool for certain types of health modeling, but not a universal fix for every single disease scenario.
Marcus: Right. It's an intermediate step, though they suggest this is the crucial bridge toward building full-model emulators that can handle even bigger simulations later on.
Ines: So we’ve seen how they cut down the runtime and improved the disability years estimate, but what does this actually mean for understanding population health patterns in the long term?
More episodes
- 2610.33881-Sensorimotor behavior from an untrained brain-and-nerve-cord connectome
- 2610.40344-Morphological Features of Murine Pulmonary Arterial Networks for Diagnosing Vascular Disease
- Daily Summary for 2026-11-19
- 2609.10193-Are You Learning Biological Signal or Shortcuts? Auditing and Mitigating Bias in Protein-Protein Interaction Datasets
- 2610.38236-Generative discovery of chemical reaction networks
- 2507.11176-An Interpretable AI framework Quantifying Traditional Chinese Medicine Principles Towards Enhancing and Integrating with Modern Biomedicine
- The day in conversation for 2026-11-19
- Daily Summary for 2026-11-19
- 2504.03590-Towards a Unified Framework for Determining Conformational Ensembles of Disordered Proteins
- 2603.15217-A multiscale discrete-to-continuum framework for structured population models